用混合建模方法对热基中二甲基甲酸 (DBP) 和二甲基甲酸 (DEHP) 的风险评估
Xiangyu Bian1,2, Siyu Huang3, Dongya Chen4
1Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing 210000, China.
Toxics
|February 26, 2026
概括
热基可以含有酸盐 (PAE),但目前的污染水平不构成立即的健康风险. 先进的统计模型揭示了罕见高暴露的潜力,特别是儿童,指导未来的食品安全监测.
科学领域:
- 食品安全分析 食品安全分析
- 环境毒理学环境毒理学
- 统计建模 统计建模
背景情况:
- 由于高脂质含量,热基很容易受到甲酸 (PAE) 污染.
- 传统的风险评估模型可能会低估暴露,因为它们无法捕获极端污染值.
- 像迪布甲 (DBP) 和2-乙基) 甲 (DEHP) 这样的酸盐是常见的食品污染物.
研究的目的:
- 为了描述热基中的DBP和DEHP污染.
- 采用混合建模框架进行精确的饮食风险评估.
- 评估先进的统计模型在捕获极端暴露值方面的有效性.
主要方法:
- 使用气体染色学质谱法 (GC-MS) 分析了91个热基样本.
- 与传统的参数,极值混合 (EVMM) 和有限混合模型相匹配的度数据.
- 通过蒙特卡洛模拟对中国人口进行概率性饮食风险评估.
主要成果:
- 发现了DEHP (55%的检测) 和DBP (32%的检测) 的污染.
- 先进的模型 (玛混合物,Lognormal-Generalized Pareto) 准确地捕获了上尾污染的极端情况.
- 所有评估的危险系数 (HQ) 都低于1的安全值,其中7至13岁的儿童具有最高风险 (Max DEHP HQ = 0.68).
结论:
- 目前来自热基的甲酸盐暴露在安全范围内.
- 重尾分布突出了标准模型遗漏的零星高暴露事件的潜力.
- 7至13岁的儿童是脆弱群体;混合统计方法提高了食品安全风险分析和监管监测.
关键词:
DBP DBP DBP 的意思是说.在DEHP中,DEHP是DEHP.通过饮食暴露的食物暴露.极端价值混合物模型的模型.混合物模型模型的混合物模型参数概率模型的参数概率模型.风险评估 风险评估 风险评估更多相关视频
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
14.7K
05:05Quantification of Polybutylene Adipate Terephthalate-based Micro- and Nano-plastics from Soil Using Proton Nuclear Magnetic Resonance Spectroscopy
Published on: June 6, 2025
835
相关概念视频
01:27Pharmacodynamic Models: Overview
45
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
45
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
54
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
54